Herzog TJ, Pignata S, Ghamande SA, Rubio MJ, et al. Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer. Gynecol Oncol 2023;170:300-308.
PMID: 36758420